Psychiatric Morbidity, Illicit Drug Use and Adherence to Zidovudine (AZT) Among Injection Drug Users with HIV Disease
作者:
FerrandoStephen J.,
WallTamara L.,
BatkiSteven L.,
SorensenJames L.,
期刊:
The American Journal of Drug and Alcohol Abuse
(Taylor Available online 1996)
卷期:
Volume 22,
issue 4
页码: 475-487
ISSN:0095-2990
年代: 1996
DOI:10.3109/00952999609001674
出版商: Taylor&Francis
数据来源: Taylor
摘要:
This study describes the relationship between the need for psychiatric consultation, illicit drug use, and zidovudine (AZT) adherence in HIV-infected injection drug users (IDUs) in methadone maintenance treatment (MMT). The treatment records of 57 IDUs in MMT who had been prescribed AZT between May and August of 1991 were reviewed. Those who required psychiatric consultation (P+,N= 46, 81%) were compared with those who did not require psychiatric consultation (P-,N= 11, 19%) on adherence to AZT treatment (using the mean corpuscular volume [MCV] as a biological marker), on recent illicit drug use, and on CD4 lymphocyte (T cell) count changes from the beginning to the end of AZT treatment. The P+ subjects were less likely than P- subjects to adhere to AZT treatment: fewer in the P+ group had an MCV outside of the normal range, and P+ subjects had a lower average monthly increase in MCV since the beginning of AZT treatment. Recent illicit drug use and CD4 lymphocyte count changes from the beginning to the end of AZT treatment did not show group differences. Psychiatric morbidity among HIV-infected IDUs in MMT is common, and may contribute to poor adherence to AZT treatment. Psychiatric screening and adherence-enhancing interventions should be targeted to IDUs entering drug treatment programs.
点击下载:
PDF (614KB)
返 回